INBX Competitors & Alternatives
Compare Inhibrx Biosciences, Inc. with similar stocks in the same industry
Biotechnology
INBX
Main Stock$96.14
Tradestie Score
53
Market Cap
$492.21M
Revenue Growth
-1.0%
Analyst Upside
+177.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.95
|
$1.50B | 7.3 | 55 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$21.98
|
$1.50B | - | 54 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$29.21
|
$1.49B | - | 53 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$19.42
|
$1.43B | - | 64 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$16.75
|
$1.42B | - | 58 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$13.25
|
$1.35B | - | 63 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$27.75
|
$1.32B | - | 47 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$10.75
|
$1.29B | - | 41 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$26.17
|
$1.29B | - | 63 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.17
|
$1.29B | - | 74 | Compare |
More INBX Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry